Autism and attention-deficit/hyperactivity disorder in children with cerebral palsy: high prevalence rates in a population-based study.


Journal

Developmental medicine and child neurology
ISSN: 1469-8749
Titre abrégé: Dev Med Child Neurol
Pays: England
ID NLM: 0006761

Informations de publication

Date de publication:
03 2021
Historique:
accepted: 12 10 2020
pubmed: 19 11 2020
medline: 25 8 2021
entrez: 18 11 2020
Statut: ppublish

Résumé

To assess a total population of school-age children with cerebral palsy (CP) for autism and attention-deficit/hyperactivity disorder (ADHD) with a view to determining their prevalence and to relate findings to motor function, intellectual disability, and other associated impairments. Of 264 children, born between 1999 and 2006, from the CP register of western Sweden, 200 children (109 males, 91 females, median age at assessment 14y, range 7-18y) completed comprehensive screening and further neuropsychiatric clinical assessments. Ninety children (45%) were diagnosed with autism, ADHD, or both, 59 (30%) were diagnosed with autism, and 60 (30%) were diagnosed with ADHD. Intellectual disability was present in 51%. Two-thirds had autism, ADHD, and/or intellectual disability. In regression models, autism was mainly predicted by intellectual disability (odds ratio [OR]=4.1) and ADHD (OR=3.2), and ADHD was predicted by intellectual disability (OR=2.3) and autism (OR=3.0). Autism was more common in children born preterm (OR=2.0). Gross motor function was not associated with autism. ADHD prevalence was low in children with severe motor impairment, possibly due to diagnostic limitations. Autism and ADHD were common in this population of children with CP and were mainlyindependent of motor severity and CP type. The strongest predictor of autism/ADHD was intellectual disability. Assessment for autism and ADHD is warranted as part of the evaluation in CP. Forty-five percent of the children with cerebral palsy also had autism, attention-deficit/hyperactivity disorder (ADHD), or both. Autism and ADHD were predicted mainly by intellectual disability. Established diagnostic instruments worked well for all but the most disabled group of children.

Identifiants

pubmed: 33206380
doi: 10.1111/dmcn.14736
pmc: PMC7894137
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

320-327

Subventions

Organisme : RBU Research Foundation
Organisme : Sahlgrenska University Hospital Foundations
Organisme : Gothenburg Society of Medicine
Organisme : Linnea and Josef Carlsson Foundation
Organisme : Swedish state under the agreement between Swedish government and the country councils, the ALF-agreement
ID : ALFGBG-726001
Organisme : Queen Silvia Children´s Hospital Research Foundations

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2020 The Authors. Developmental Medicine & Child Neurology published by John Wiley & Sons Ltd on behalf of Mac Keith.

Références

Dev Med Child Neurol. 2008 Oct;50(10):744-50
pubmed: 18834387
J Autism Dev Disord. 2007 Apr;37(4):613-27
pubmed: 17180459
Arch Pediatr Adolesc Med. 2010 Feb;164(2):160-5
pubmed: 20124145
Eur Child Adolesc Psychiatry. 2020 Nov;29(11):1569-1579
pubmed: 31927764
Acta Paediatr. 2014 Jun;103(6):618-24
pubmed: 24575788
Acta Paediatr. 2010 Sep;99(9):1337-43
pubmed: 20377538
Source Code Biol Med. 2008 Dec 16;3:17
pubmed: 19087314
Dev Med Child Neurol. 2014 Jan;56(1):59-65
pubmed: 24117446
Dev Med Child Neurol. 2005 Mar;47(3):193-8
pubmed: 15739725
J Am Acad Child Adolesc Psychiatry. 2001 Feb;40(2):168-79
pubmed: 11211365
J Autism Dev Disord. 1980 Mar;10(1):91-103
pubmed: 6927682
Res Dev Disabil. 2013 Oct;34(10):3202-10
pubmed: 23891732
J Autism Dev Disord. 2012 Jul;42(7):1491-7
pubmed: 22048962
Dev Med Child Neurol. 2000 Dec;42(12):816-24
pubmed: 11132255
Dev Med Child Neurol Suppl. 2007 Feb;109:8-14
pubmed: 17370477
Dev Med Child Neurol. 2006 Jun;48(6):417-23
pubmed: 16700930
Res Dev Disabil. 2012 Jul-Aug;33(4):1287-93
pubmed: 22502856
Eur J Paediatr Neurol. 2019 Jan;23(1):31-42
pubmed: 30446273
Dev Med Child Neurol. 2009 Apr;51(4):289-94
pubmed: 19335564
BMJ. 2015 Apr 28;350:h1961
pubmed: 25922345
BMJ. 1996 Apr 27;312(7038):1065-9
pubmed: 8616413
Acta Paediatr. 2019 Nov;108(11):2048-2055
pubmed: 31077607
Res Dev Disabil. 2010 Nov-Dec;31(6):1543-51
pubmed: 20634041
Front Psychiatry. 2019 Jul 30;10:526
pubmed: 31417436
J Child Psychol Psychiatry. 2002 Mar;43(3):307-25
pubmed: 11944874
Dev Med Child Neurol. 2009 May;51(5):356-63
pubmed: 19388148
Dev Med Child Neurol. 2017 Jul;59(7):738-742
pubmed: 28439889

Auteurs

Magnus Påhlman (M)

Gillberg Neuropsychiatry Centre, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Regional Rehabilitation Centre, Queen Silvia Children's Hospital, Gothenburg, Sweden.

Christopher Gillberg (C)

Gillberg Neuropsychiatry Centre, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

Kate Himmelmann (K)

Regional Rehabilitation Centre, Queen Silvia Children's Hospital, Gothenburg, Sweden.
Department of Pediatrics, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH